As Insurers Sit on Extra Cash, Are Premium Relief and MLR Rebates the Best Use of Funds?

While the COVID-19 pandemic has prompted financial catastrophe across the country, the private health insurance industry appears to be thriving. CHIR researchers Megan Houston and Sabrina Corlette consider whether the traditional use of these extra funds is the best way to spend them and discuss opportunities that states may have to redirect money towards COVID-19 testing. Continue reading

State Options Blog Series: Implications of Weakening the 80-20 Rule for States and Consumers

The Trump administration recently issued a proposed regulation that could significantly impact how much of consumers’ premium dollars are spent on their health care needs. CHIR expert Kevin Lucia assesses the proposed relaxation of the Affordable Care Act’s “80-20” or medical loss ratio standards and outlines policy options for states wishing to maintain them. Continue reading